Latest news

Search
Categories
News archive

Nanologica’s Year-End Report 2022

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 674 (676) and for the full year to TSEK 1,555 (12,914) The operating loss for the quarter amounted to TSEK -13,251 (-14,108) and for the full year to TSEK -50,850 (-40,689) Loss after tax for the quarter amounted to TSEK -14,855 (-15,222) and for the full year to TSEK -55,231 (-44,829) Earnings per share before and after dilution were SEK -0.42 (-0.54) for the

Read more »

Nanologicas bokslutskommuniké 2022

FINANSIELL SAMMANFATTNING Nettoomsättningen för fjärde kvartalet uppgick till 674 TSEK (676) och för helåret till 1 555 TSEK (12 914) Rörelseresultatet för kvartalet uppgick till -13 251 TSEK (-14 108) och för helåret till -50 850 TSEK (-40 689) Resultatet efter skatt för kvartalet uppgick till -14 855 TSEK (-15 222) och för helåret till -55 231 TSEK (-44 829) Resultat per aktie före och efter utspädning var -0,42 SEK (-0,54) för kvartalet och för

Read more »

CEO Comment Q3 2023

WELL-POSITIONED FOR THE NEXT PHASE Our focus during the third quarter has mainly been on production and financing. We are now producing on a large scale in our production line, while having secured financing to intensify our investments in preparative chromatography and deliver on the order book we are starting to build. During the third quarter, we received several orders for the evaluation of NLAB Saga®, our silica for preparative chromatography, including one order from

Read more »

Nanologica’s Interim Report Jan-Sep 2022

Nanologica AB’s Interim Report Jan-Sep 2022 The auditor’s report Q3 2022 (Swedish) Report presentation Q3 2022   FINANCIAL SUMMARY Net sales for the third quarter amounted to TSEK 401 (2,119) and for the nine-month period to TSEK 881 (12,238) The operating result for the quarter amounted to TSEK -9,610 (-11,718) and for the nine-month period to TSEK -37,599 (-26,581) Result after tax for the quarter amounted to TSEK -10,988 (-12,546) and for the nine-month period

Read more »